Access content directly

Stéphane Gibaud

39
Documents
Researcher identifiers

Presentation

Research Team : CITHEFOR/EA3452 - Lorraine University (Nancy, France) Centre Hospitalier de l'Ouest Vosgien (Pharmacie à Usage Intérieur) : Chief Pharmacist
Equipe CITHEFOR/EA3452 - Université de Lorraine Centre Hospitalier de l'Ouest Vosgien (Pharmacie à Usage Intérieur) : Pharmacien Gérant

Publications

Image document

Succinimido–Ferrocidiphenol Complexed with Cyclodextrins Inhibits Glioblastoma Tumor Growth In Vitro and In Vivo without Noticeable Adverse Toxicity

Feten Najlaoui , Benoît Busser , Germain Sotoing Taïwe , Pascal Pigeon , Nathalie Sturm et al.
Molecules, 2022, 27 (14), pp.4651. ⟨10.3390/molecules27144651⟩
Journal articles hal-03736856v1
Image document

Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues

Emilie Belissa , Thibault Vallet , Sandra Laribe-Caget , Alain Chevallier , François-Xavier Chedhomme et al.
BMC Geriatrics, 2019, 19 (1), pp.344. ⟨10.1186/s12877-019-1337-2⟩
Journal articles hal-02922911v1
Image document

A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population

Thibault Vallet , Emilie Belissa , Sandra Laribe-Caget , Alain Chevallier , François-Xavier Chedhomme et al.
Pharmaceutical Research, 2018, 35 (7), pp.136. ⟨10.1007/s11095-018-2424-3⟩
Journal articles hal-01793642v1
Image document

Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives

Feten Najlaoui , Pascal Pigeon , Sonia Aroui , Mylène Pezet , Lucie Sancey et al.
Journal of Pharmacy and Pharmacology, 2018, 70 (11), pp.1474-1484. ⟨10.1111/jphp.12998⟩
Journal articles hal-01861749v1

Spray-dried microparticles of glutathione and S-nitrosoglutathione based on Eudragit® FS 30D polymer

S. Shah , M. Socha , C. Sejil , Stéphane Gibaud
Annales Pharmaceutiques Françaises, 2017, 75 (2), pp.95-104. ⟨10.1016/j.pharma.2016.09.001⟩
Journal articles hal-01875168v1

The effect of intravenous isosorbide dinitrate in acute decompensated heart failure in hospital

Jérémy Chambord , David Attivi , Thuus Véronique , Claire Zeghmouli , Stéphane Gibaud et al.
International Journal of Clinical Pharmacy, 2017, 39 (3), pp.536-541. ⟨10.1007/s11096-017-0459-x⟩
Journal articles hal-01503313v1
Image document

Thiomers and their potential applications in drug delivery

Kifayat Ullah Ullah Shah , Shefaat Ullah Shah , Naz Dilawar , Gul Majid Khan , Stéphane Gibaud et al.
Expert Opinion on Drug Delivery, 2016, 14 (5), pp.601-610. ⟨10.1080/17425247.2016.1227787⟩
Journal articles hal-01377809v1
Image document

Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines

Shefaat Ullah Shah , Marie Socha , Isabelle Fries , Stéphane Gibaud
Drug Delivery, 2016, 23 (8), pp.2927-2935. ⟨10.3109/10717544.2015.1122676⟩
Journal articles hal-01288115v1

Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity

Feten Najlaoui , Pascal Pigeon , Zaineb Abdelkafi , Sebastien Leclerc , Pierrick Durand et al.
International Journal of Pharmaceutics, 2015, 491 (1-2), pp.323-334. ⟨10.1016/j.ijpharm.2015.06.043⟩
Journal articles hal-01218567v1

Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor

Shefaat Ullah Shah , Nuno Martinho , Marie Socha , Catarina Pinto Reis , Stéphane Gibaud et al.
Expert Opinion on Drug Delivery, 2015, 12 (8), pp.1209-1223. ⟨10.1517/17425247.2015.1028916⟩
Journal articles hal-01280370v1
Image document

Effect of intravenous hydration in patients receiving bisphosphonate therapy

David Attivi , Gaétan Kosmalski , Claire Zeghmouli , Stéphane Gibaud
International Journal of Clinical Pharmacy, 2014, 36 (6), pp.1277-1281. ⟨10.1007/s11096-014-9994-x⟩
Journal articles hal-01169102v1

Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?

David Attivi , Stéphane Gibaud
Annales Pharmaceutiques Françaises, 2014, 72 (3), pp.146-151. ⟨10.1016/j.pharma.2013.12.006⟩
Journal articles hal-01291788v1
Image document

The antitumor effects of an arsthinol–cyclodextrin complex in a heterotopic mouse model of glioma

Selma Becherirat , Marie-Claire Lanhers , Marie Socha , Mehdi Yemloul , Alain Astier et al.
European Journal of Pharmaceutics and Biopharmaceutics, 2013, 83 (3 Pt A), pp.560-568. ⟨10.1016/j.ejpb.2013.06.021⟩
Journal articles hal-01169157v1

Characterization of mitotane (o,p′-DDD) – cyclodextrin inclusion complexes: Phase-solubility method and NMR

R. Alfonsi , D. Attivi , A. Astier , Marie Socha , S. Morice et al.
Annales Pharmaceutiques Françaises, 2013, 71 (3), pp.186-92. ⟨10.1016/j.pharma.2013.02.001⟩
Journal articles hal-01290439v1
Image document

Microemulsions for oral administration and their therapeutic applications.

Stéphane Gibaud , David Attivi
Expert Opinion on Drug Delivery, 2012, 9 (8), epub ahead of print. ⟨10.1517/17425247.2012.694865⟩
Journal articles hal-00706176v1
Image document

Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis

Jean Rodgers , Amy Jones , Stéphane Gibaud , Barbara Bradley , Christopher Mccabe et al.
PLoS Neglected Tropical Diseases, 2011, 5 (9), pp.e1308. ⟨10.1371/journal.pntd.0001308⟩
Journal articles hal-00689712v1

Speciation of arsenic in urine following intravenous administration of arsthinol in mice.

Imane Ajana , Alain Astier , Stéphane Gibaud
European journal of drug metabolism and pharmacokinetics, 2010, 35 (1-2), pp.59-65. ⟨10.1007/s13318-010-0009-6⟩
Journal articles hal-00689713v1

Development of microemulsion of mitotane for improvement of oral bioavailability.

David Attivi , Imane Ajana , Alain Astier , Béatrice Demoré , Stéphane Gibaud et al.
Drug Development and Industrial Pharmacy, 2010, 36 (4), pp.421-7. ⟨10.3109/03639040903225083⟩
Journal articles hal-00689714v1

Arsenic-Based Drugs: From Fowler’s Solution to Modern Anticancer Chemotherapy

Stéphane Gibaud , Gérard Jaouen
Topics in Organometallic Chemistry, 2010, 32, pp.1-20. ⟨10.1007/978-3-642-13185-1⟩
Journal articles hal-01395677v1
Image document

Arsthinol nanosuspensions: pharmacokinetics and antileukemic activity on NB4 promyelocytic leukemia cells

Imane Ajana , Alain Astier , Stéphane Gibaud
J Pharm Pharmacol, 2009, 61 (10), pp.1295-301. ⟨10.1211/jpp/61.10.0004⟩
Journal articles hal-00689719v1

Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice.

Siham Ben Zirar , Alain Astier , Marc Muchow , Stéphane Gibaud
European Journal of Pharmaceutics and Biopharmaceutics, 2008, 70 (2), pp.649-56. ⟨10.1016/j.ejpb.2008.05.012⟩
Journal articles hal-00399636v1

Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice

Siham Ben Zirar , Stéphane Gibaud , Camut Alexandra , Alain Astier
Journal of Organometallic Chemistry, 2007, 692 (6), pp.1348-1352. ⟨10.1016/j.jorganchem.2006.10.034⟩
Journal articles hal-01395675v1

Organoarséniés dérivés du 2-phényl- [1,3,2]dithiarsolane-4-yl)-méthanol (AsIII) à propriétés antileucémiques : des trypanosomicides aux anticancéreux

Stéphane Gibaud , A. Astier
Annales Pharmaceutiques Françaises, 2007, 65 (3), pp.162-8. ⟨10.1016/s0003-4509(07)90031-0⟩
Journal articles hal-00399635v1

Cyclodextrin inclusion complexes of the central analgesic drug nefopam.

H. Brun , M. Paul , N. Razzouq , M. Binhas , Stéphane Gibaud et al.
Drug Development and Industrial Pharmacy, 2006, 32 (10), pp.1123-34. ⟨10.1080/03639040600920663⟩
Journal articles hal-00399631v1

(2-Phenyl-[1,3,2]dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity

Stéphane Gibaud , Raphaël Alfonsi , Pierre Mutzenhardt , Isabelle Fries , Alain Astier et al.
Journal of Organometallic Chemistry, 2006, 691, pp.1081-1084. ⟨10.1016/j.jorganchem.2005.11.007⟩
Journal articles hal-00125073v1
Image document

Melarsoprol-cyclodextrins inclusion complexes.

Stéphane Gibaud , Siham Ben Zirar , Pierre Mutzenhardt , Isabelle Fries , Alain Astier et al.
International Journal of Pharmaceutics, 2005, 306 (1-2), pp.107-21. ⟨10.1016/j.ijpharm.2005.09.003⟩
Journal articles hal-00399630v1

Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate.

Stéphane Gibaud , Najim Jabir Al Awwadi , Camille Ducki , Alain Astier
International Journal of Pharmaceutics, 2004, 269 (2), pp.491-508
Journal articles hal-00399629v1

Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.

Stéphane Gibaud , Aurélie Bonneville , Alain Astier
International Journal of Pharmaceutics, 2002, 242 (1-2), pp.197-201
Journal articles hal-00399627v1

Slow-release melarsoprol microparticles.

Stéphane Gibaud , Adela Gaia , Alain Astier
International Journal of Pharmaceutics, 2002, 243 (1-2), pp.161-6
Journal articles hal-00399626v1

Ciblage de la moelle osseuse à l'aide de nanoparticules de polyalkylcyanoacrylate

S. Gibaud , C. Weingarten , J. P. Andreux , P. Couvreur
Annales Pharmaceutiques Françaises, 1999, 57 (4), pp.324-31
Journal articles hal-00399628v1

Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF).

S. Gibaud , Chloé Rousseau , C. Weingarten , R. Favier , L. Douay et al.
Journal of Controlled Release, 1998, 52 (1-2), pp.131-9
Journal articles hal-00399625v1

Polyisobutylcyanoacrylate nanoparticles as drug carriers: influence of sulfur dioxide on the physico-chemical characteristics of ciprofloxacin- and doxorubicin-loaded nanoparticles

Marie-Estelle Page-Clisson , Stéphane Gibaud , Huguette Pinto-Alphandary , Colette Weingarten , Patrick Couvreur et al.
International Journal of Pharmaceutics, 1998, 166, pp.117-120. ⟨10.1016/S0378-5173(98)00028-3⟩
Journal articles hal-01383588v1

Splenic trapping of nanoparticles: complementary approaches for in situ studies.

M. Demoy , Stéphane Gibaud , J. P. Andreux , C. Weingarten , B. Gouritin et al.
Pharmaceutical Research, 1997, 14 (4), pp.463-8
Journal articles hal-00689718v1

Cells involved in the capture of nanoparticles in hematopoietic organs.

S. Gibaud , M. Demoy , J. P. Andreux , C. Weingarten , B. Gouritin et al.
Journal of Pharmaceutical Sciences, 1996, 85 (9), pp.944-50. ⟨10.1021/js960032d⟩
Journal articles hal-00399624v1

Increased bone marrow toxicity of doxorubicin bound to nanoparticles.

S. Gibaud , J. P. Andreux , C. Weingarten , Maurice Renard , P. Couvreur et al.
European Journal of Cancer, 1994, 30A (6), pp.820-6
Journal articles hal-00399622v1

Increased bone marrow toxicity of doxorubicin bound to nanoparticles

Stéphane Gibaud , Andreux Jean-Paul , Colette Weingarten , Michèle Renard , Patrick Couvreur et al.
European Journal of Cancer, 1994, 30A (6), pp.820-826. ⟨10.1016/0959-8049(94)90299-2⟩
Journal articles hal-01383605v1

Detection of bacterial adenosine triphosphate through bioluminescence, applied to a rapid sterility test of injectable preparations

F C Decool , V Goury , A Tibi , S Gibaud , F Vincent et al.
Analytica Chimica Acta, 1991, 255, pp.423 - 425. ⟨10.1016/0003-2670(91)80078-8⟩
Journal articles hal-01383025v1

CHAPTER 8. Arsenic-based Anticancer Agents

Stéphane Gibaud
Casini, Angela; Vessières, Anne; Meier-Menches, Samuel M. Metal-based Anticancer Agents, Royal Society of Chemistry, pp.196-214, 2019, 978-1-78801-406-9. ⟨10.1039/9781788016452-00196⟩
Book sections hal-02112897v1